Skip to main content
Premium Trial:

Request an Annual Quote

BioSystems International Licenses Northeastern s Biomarker Discovery Platform

NEW YORK, March 10 (GenomeWeb News) - BioSystems International will license from NortheasternUniversity its monoclonal antibody-based biomarker-discovery and -development platform.

 

The platform was developed by scientists at Pfizer Fresnes Laboratories and NortheasternUniversity. Pfizer retains rights to use the technology for its programs.

 

Terms of the agreement were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.